While the candidate achieved pharmacokinetic objectives, the program was discontinued due to a single case of potential liver injury among over 1,400 trial participants
For instance, a head-to-head trial demonstrated that participants using Tirzepatide experienced an average weight loss of 20.2%, compared to 13.7% with Semaglutide
In mice, efocipegtruride has been shown to be able to reduce body weight by 43% after 4 weeks of treatment
In flying this distance he has spent the equivalent of 250 entire days, or more than eight months, in the air." October 1926: "AEROPLANE BLOWN BACKWARDS CAUGHT BY STRONG WIND AND CARRIED FOR MILE

1 In adults with obesity, along with diet and exercise, A well-studied safety profile for adults with obesity: Pooled safety data from 2 weight-management clinical trials evaluating Wegovy HD 7.2 mg 1 Wegovy HD (semaglutide) injection 7.2 mg had a safety profile consistent with Wegovy 2.4 mg 1,3 5% of patients with Wegovy HD 7.2 mg pen, 5% of patients with Wegovy 2.4 mg pen, and 2% of patients with placebo permanently discontinued as a result of adverse reactions 1 The most common adverse reactions leading to discontinuation were gastrointestinal disorders: 3% of patients with Wegovy HD 7.2 mg pen, 3% of patients with Wegovy 2.4 mg pen, and 0.3% of patients with placebo 1 Includes allodynia, burning sensation, dysesthesia, hyperesthesia, hyperpathia, pain of skin, paresthesia, sensitive skin, skin burning sensation, skin discomfort, and skin sensitization

For this reason and due to potential side effects you should ask your healthcare provider to help you find a high-quality supplement from a reputable manufacturer